{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T06:46:32Z","timestamp":1720507592587},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.drugpo.2017.09.008","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T19:03:06Z","timestamp":1510858986000},"page":"18-19","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Survey representativeness, quantifying uncertainty, and the importance of well-posed questions about the administration of take-home naloxone"],"prefix":"10.1016","volume":"51","author":[{"given":"Sheila M.","family":"Bird","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugpo.2017.09.008_bib0005","series-title":"Evaluation of the take home demonstration project","author":"Bennett","year":"2011"},{"key":"10.1016\/j.drugpo.2017.09.008_bib0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(14)60022-2","article-title":"Does take-home naloxone reduce non-fatal overdose?","volume":"383","author":"Bennett","year":"2014","journal-title":"The Lancet"},{"key":"10.1016\/j.drugpo.2017.09.008_bib0015","first-page":"66","article-title":"Take-home naloxone to prevent fatalities from opiate-overdose: Protocol for Scotland\u2019s public health policy evaluation, and a new measure to assess impact","volume":"22","author":"Bird","year":"2015","journal-title":"Drugs: Education Prevention and Policy"},{"key":"10.1016\/j.drugpo.2017.09.008_bib0020","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/add.13265","article-title":"Effectiveness of Scotland\u2019s National Naloxone Programme for reducing opioid-related deaths: A before (2006\u201310) versus after (2011\u201313) comparison","volume":"111","author":"Bird","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2017.09.008_bib0025","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(17)30656-6","article-title":"Prison-based prescription of take-home naloxone for persons who inject drugs contributes to the effectiveness of Scotland\u2019s National Naloxone Policy, 2011\u20132015","volume":"389","author":"Bird","year":"2017","journal-title":"The Lancet"},{"key":"10.1016\/j.drugpo.2017.09.008_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.conctc.2017.01.006","article-title":"External data required timely response by the Trial Steering-Data Monitoring Committee for the NALoxone InVEstigation (N-ALIVE) pilot trial","volume":"5","author":"Bird","year":"2017","journal-title":"Contemporary Clinical Trials Communications"},{"key":"10.1016\/j.drugpo.2017.09.008_bib0035","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/14659891.2015.1063718","article-title":"Non-fatal overdose among opiate users in Wales: A national survey","volume":"21","author":"Holloway","year":"2016","journal-title":"Journal of Substance Use"},{"key":"10.1016\/j.drugpo.2017.09.008_bib0040","first-page":"1","article-title":"Estimating prevalence of injecting drug users and associated heroin-related death-rates in England using regional data and incorporating prior information","volume":"177","author":"King","year":"2014","journal-title":"Journal of the Royal Statistical Series A"},{"key":"10.1016\/j.drugpo.2017.09.008_bib0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugpo.2017.05.017","article-title":"The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland","volume":"46","author":"O\u2019Halloran","year":"2017","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2017.09.008_bib0050","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/add.13668","article-title":"Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths","volume":"112","author":"Parmar","year":"2017","journal-title":"Addiction"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917302864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917302864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T20:57:30Z","timestamp":1535230650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395917302864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":10,"alternative-id":["S0955395917302864"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.09.008","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survey representativeness, quantifying uncertainty, and the importance of well-posed questions about the administration of take-home naloxone","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}